Doctor Anna Damlin
Karolinska Institute, Stockholm (Sweden)
Member of:
/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Navigating hypertrophic cardiomyopathy echo imaging with cardiac myosin inhibitors
Event: ESC Congress 2024
Topic: Hypertrophic Cardiomyopathy
Session: Navigating hypertrophic cardiomyopathy echo imaging with cardiac myosin inhibitors
Navigating hypertrophic cardiomyopathy (HCM) echo imaging with cardiac myosin inhibitors
Event: ESC Congress 2024
Topic: Hypertrophic Cardiomyopathy
Session: Navigating hypertrophic cardiomyopathy (HCM) echocardiographic imaging with cardiac myosin inhibitors
Sex-based differences in anatomical and hemodynamic parameters and outcomes in patients with hypertrophic cardiomyopathy undergoing alcohol septal ablation
Event: ESC Congress 2024
Topic: Epidemiology, Prognosis, Outcome
Session: Hypertrophic and other cardiomyopathies: miscellaneous findings
Suggested modification of the recommendations for echocardiography in patients with clinical suspicion of infective endocarditis
Event: EuroEcho 2021
Topic: Transoesophageal Echocardiography (TOE)
Session: e-posters session - Echocardiography
Relationships between bacteria and echocardiographic manifestations in infective endocarditis - data from the Swedish endocarditis registry
Event: ESC Congress 2019
Topic: Diagnostic Methods
Session: Endocarditis: pathophysiology, clinical features and management
